abiraterone,olaparib,abiraterone
astrazeneca,merck
['abira', 'prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'olaparib', 'propel', 'abiraterone']
#ascogu23 highlight. prof. noel clarke presents today in the 'general session: advanced prostate cancer' the final survival data from the propel trial: abiraterone &amp; olaparib versus abiraterone &amp; placebo as first-line therapy for mcrpc. #meded #gu23 
COR2ED bringing you Independent Medical Education developed 
by GU CONNECT, international experts in GenitoUrinary (GU) oncology